These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 294134)

  • 1. Proliferative lesion of arthritis: a target for therapy?
    Van De Putte LB; Van Beusekom HJ
    Agents Actions Suppl; 1979; (5):169-178. PubMed ID: 294134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intercellular messengers in joint tissues in rheumatoid arthritis. How disturbed control mechanisms may contribute to tissue destruction and repair.
    Russell RG; McGuire MK; Meats JE; Ebsworth NM; Beresford J
    Scand J Rheumatol Suppl; 1981; 40():75-87. PubMed ID: 6100920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rheumatoid arthritis: targeting the proliferative fibroblasts.
    Kramer I; Wibulswas A; Croft D; Genot E
    Prog Cell Cycle Res; 2003; 5():59-70. PubMed ID: 14593701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cells of the synovium in rheumatoid arthritis. Synovial fibroblasts.
    Müller-Ladner U; Ospelt C; Gay S; Distler O; Pap T
    Arthritis Res Ther; 2007; 9(6):223. PubMed ID: 18177509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone and joint destruction in rheumatoid arthritis: what is really happening?
    Goldring SR
    J Rheumatol Suppl; 2002 Sep; 65():44-8. PubMed ID: 12236623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel gene therapy for rheumatoid arthritis by FADD gene transfer: induction of apoptosis of rheumatoid synoviocytes but not chondrocytes.
    Kobayashi T; Okamoto K; Kobata T; Hasunuma T; Kato T; Hamada H; Nishioka K
    Gene Ther; 2000 Mar; 7(6):527-33. PubMed ID: 10757027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Possible correction of abnormal rheumatoid arthritis synovial cell function by jun D transfection in vitro.
    Wakisaka S; Suzuki N; Saito N; Ochi T; Sakane T
    Arthritis Rheum; 1998 Mar; 41(3):470-81. PubMed ID: 9506576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morphological and molecular pathology of the B cell response in synovitis of rheumatoid arthritis.
    Magalhães R; Stiehl P; Morawietz L; Berek C; Krenn V
    Virchows Arch; 2002 Nov; 441(5):415-27. PubMed ID: 12447670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mode of action of D-penicillamine in chronic polyarthritis. 1. Protein synthesis inhibition in synovial fluid cells].
    Bröll H; Altmann H; Kocsis R; Tausch G
    Z Rheumatol; 1978; 37(1-2):51-5. PubMed ID: 629096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Penicillamine in rheumatoid arthritis. Connective tissue changes and alterations in serum copper and phase reactants in relation to clinical improvement.
    Hansen TM; Manthorpe R; Kofod B; Andreassen T; Oxlund H; Lorenzen IB
    J Rheumatol; 1976 Dec; 3(4):367-74. PubMed ID: 1022870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mode of action of D-penicillamine in chronic polyarthritis. 2. Studies on DNA repair in synovial fluid cells following intra-articular administration of D-penicillamine].
    Bröll H; Altmann H; Kocsis F; Klein W
    Z Rheumatol; 1978; 37(1-2):56-9. PubMed ID: 629097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth hormone, VEGF and FGF: involvement in rheumatoid arthritis.
    Malemud CJ
    Clin Chim Acta; 2007 Jan; 375(1-2):10-9. PubMed ID: 16893535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cysteine proteinase cathepsin K mRNA is expressed in synovium of patients with rheumatoid arthritis and is detected at sites of synovial bone destruction.
    Hummel KM; Petrow PK; Franz JK; Müller-Ladner U; Aicher WK; Gay RE; Brömme D; Gay S
    J Rheumatol; 1998 Oct; 25(10):1887-94. PubMed ID: 9779840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Recent progress of pathogenesis and treatments in rheumatoid arthritis].
    Tanaka Y
    Clin Calcium; 2005 Jul; 15(7):23-8. PubMed ID: 15995292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of vascular cell adhesion molecule 1/ very late activation antigen 4 in endothelial progenitor cell recruitment to rheumatoid arthritis synovium.
    Silverman MD; Haas CS; Rad AM; Arbab AS; Koch AE
    Arthritis Rheum; 2007 Jun; 56(6):1817-26. PubMed ID: 17530710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of mesenchymal cells in the pathophysiology of inflammatory arthritis.
    Meyer LH; Franssen L; Pap T
    Best Pract Res Clin Rheumatol; 2006 Oct; 20(5):969-81. PubMed ID: 16980218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pathophysiology of rheumatoid arthritis].
    Morović-Vergles J
    Reumatizam; 2003; 50(2):15-7. PubMed ID: 15098367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Repair of bone and articular destruction in rheumatoid arthritis].
    Kanbe K
    Clin Calcium; 2007 Apr; 17(4):541-5. PubMed ID: 17404483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CXCL12 chemokine up-regulates bone resorption and MMP-9 release by human osteoclasts: CXCL12 levels are increased in synovial and bone tissue of rheumatoid arthritis patients.
    Grassi F; Cristino S; Toneguzzi S; Piacentini A; Facchini A; Lisignoli G
    J Cell Physiol; 2004 May; 199(2):244-51. PubMed ID: 15040007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Morphological evaluation and classification of synovial tissue].
    Fassbender HG
    Verh Dtsch Ges Rheumatol; 1972; 2():Suppl 2:47-52. PubMed ID: 5051969
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.